Vavricka John 4
4 · Atea Pharmaceuticals, Inc. · Filed Feb 2, 2023
Insider Transaction Report
Form 4
Vavricka John
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2023-01-31+100,000→ 100,000 total→ Common Stock (100,000 underlying) - Award
Stock Option (Right to Buy)
2023-01-31+140,000→ 140,000 totalExercise: $4.63Exp: 2033-01-30→ Common Stock (140,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026.
- [F3]The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027.